BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17034947)

  • 21. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.
    Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G
    DNA Repair (Amst); 2012 Apr; 11(4):374-80. PubMed ID: 22284908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas.
    Li D; Chen P; Li XY; Zhang LY; Xiong W; Zhou M; Xiao L; Zeng F; Li XL; Wu MH; Li GY
    OMICS; 2011 Oct; 15(10):673-82. PubMed ID: 21978395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA repair gene XRCC4 codon 247 polymorphism modified diffusely infiltrating astrocytoma risk and prognosis.
    Lin ZH; Chen JC; Wang YS; Huang TJ; Wang J; Long XD
    Int J Mol Sci; 2013 Dec; 15(1):250-60. PubMed ID: 24378850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas.
    Scrideli CA; Carlotti CG; Mata JF; Neder L; Machado HR; Oba-Sinjo SM; Rosemberg S; Marie SK; Tone LG
    J Neurooncol; 2007 Jul; 83(3):233-9. PubMed ID: 17285230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
    Zhi F; Wang Q; Xue L; Shao N; Wang R; Deng D; Wang S; Xia X; Yang Y
    PLoS One; 2015; 10(8):e0135242. PubMed ID: 26252651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
    Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
    BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors.
    Ferreira WA; Araújo MD; Anselmo NP; de Oliveira EH; Brito JR; Burbano RR; Harada ML; Borges Bdo N
    PLoS One; 2015; 10(8):e0137259. PubMed ID: 26317630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
    Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
    Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
    Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
    J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas.
    Wang C; Funk CC; Eddy JA; Price ND
    PLoS One; 2013; 8(10):e76694. PubMed ID: 24146911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
    Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
    Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
    Kotoula V; Barbanis S; Nikolakaki E; Koufoyannis D; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2004 May; 107(5):443-51. PubMed ID: 14986029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade.
    Zhu SJ; Wang KJ; Gan SW; Xu J; Xu SY; Sun SQ
    Biochem Biophys Res Commun; 2013 Oct; 440(1):168-72. PubMed ID: 24055034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three meta-analyses define a set of commonly overexpressed genes from microarray datasets on astrocytomas.
    Liu Z; Xie M; Yao Z; Niu Y; Bu Y; Gao C
    Mol Neurobiol; 2013 Feb; 47(1):325-36. PubMed ID: 23135747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression study of DNA translesion synthesis genes in human primary glioma].
    Xi CH; Hu J; Wang HB; Zhang SY; Ru DL
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1309-12. PubMed ID: 19615182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.
    Marie SK; Okamoto OK; Uno M; Hasegawa AP; Oba-Shinjo SM; Cohen T; Camargo AA; Kosoy A; Carlotti CG; Toledo S; Moreira-Filho CA; Zago MA; Simpson AJ; Caballero OL
    Int J Cancer; 2008 Feb; 122(4):807-15. PubMed ID: 17960622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.